Search Press releases Keywords From To 25 May 2022 Transparency notification FMR LLC Read More 25 May 2022 Transparency notification FMR LLC Read More 24 May 2022 Transparency notification FMR LLC Read More 23 May 2022 First Presentations of Phase 3 Data for Bimekizumab Across the Full Spectrum of Axial Spondyloarthritis to be Shared at EULAR 2022 Read More 23 May 2022 UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be Presented at EULAR 2022 Read More 20 May 2022 Disposal of own shares Read More Pagination First page Previous page Previous … Page 36 Page 37 Page 38 Page 39 Current page 40 Page 41 Page 42 Page 43 Page 44 … Page 40 of 60 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
